| Effect of cigarette smoking on haematological parameters in healthy population M Malenica, B Prnjavorac, T Bego, T Dujic, S Semiz, S Skrbo, A Gusic, ... Medical Archives 71 (2), 132, 2017 | 235 | 2017 |
| Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin K Zhou, SW Yee, EL Seiser, N Van Leeuwen, R Tavendale, AJ Bennett, ... Nature genetics 48 (9), 1055-1059, 2016 | 210 | 2016 |
| Conventional kinesin KIF5B mediates insulin-stimulated GLUT4 movements on microtubules S Semiz, JG Park, SMC Nicoloro, P Furcinitti, C Zhang, A Chawla, ... The EMBO journal 22 (10), 2387-2399, 2003 | 193 | 2003 |
| Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes T Dujic, A Causevic, T Bego, M Malenica, Z Velija‐Asimi, ER Pearson, ... Diabetic Medicine 33 (4), 511-514, 2016 | 149 | 2016 |
| Analysis of insulin signalling by RNAi-based gene silencing QL Zhou, JG Park, ZY Jiang, JJ Holik, P Mitra, S Semiz, A Guilherme, ... Biochemical Society Transactions 32 (5), 817-821, 2004 | 118 | 2004 |
| Variants in pharmacokinetic transporters and glycemic response to metformin: a Metgen meta‐analysis T Dujic, K Zhou, SW Yee, N van Leeuwen, CE de Keyser, M Javorský, ... Clinical Pharmacology & Therapeutics 101 (6), 763-772, 2017 | 116 | 2017 |
| Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study J Liu, S Semiz, SJ van der Lee, A van der Spek, A Verhoeven, ... Metabolomics 13, 1-11, 2017 | 98 | 2017 |
| Pharmacogenetics and personalized treatment of type 2 diabetes S Semiz, T Dujic, A Causevic Biochemia medica 23 (2), 154-171, 2013 | 79 | 2013 |
| Relevance of uric acid in progression of type 2 diabetes mellitus A Čaušević, S Semiz, A Macić-Džanković, B Cico, T Dujić, M Malenica, ... Bosnian journal of basic medical sciences 10 (1), 54, 2010 | 76 | 2010 |
| A Mendelian randomization study of metabolite profiles, fasting glucose, and type 2 diabetes J Liu, JB Van Klinken, S Semiz, KW Van Dijk, A Verhoeven, T Hankemeier, ... Diabetes 66 (11), 2915-2926, 2017 | 56 | 2017 |
| Drug interactions with statins A Causevic-Ramosevac, S Semiz Acta pharmaceutica 63 (3), 277-293, 2013 | 55 | 2013 |
| Association of FTO gene variant (rs8050136) with type 2 diabetes and markers of obesity, glycaemic control and inflammation T Bego, A Čaušević, T Dujić, M Malenica, Z Velija-Asimi, B Prnjavorac, ... Journal of medical biochemistry 38 (2), 153, 2019 | 54 | 2019 |
| Effects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats S Semiz, C Orvig, JH McNeill Molecular and cellular biochemistry 231, 23-35, 2002 | 52 | 2002 |
| Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity S Semiz, JH McNeill Molecular and cellular biochemistry 236, 123-131, 2002 | 48 | 2002 |
| Vanadium as potential therapeutic agent for COVID-19: A focus on its antiviral, antiinflamatory, and antihyperglycemic effects S Semiz Journal of Trace Elements in Medicine and Biology 69, 126887, 2022 | 46 | 2022 |
| Association of PPARG and LPIN1 gene polymorphisms with metabolic syndrome and type 2 diabetes T Bego, T Dujic, B Mlinar, S Semiz, M Malenica, B Prnjavorac, B Ostanek, ... Med Glas (Zenica) 8 (1), 76-83, 2011 | 42 | 2011 |
| Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome Z Velija-Asimi, A Burekovic, T Dujic, A Dizdarevic-Bostandzic, S Semiz Bosnian journal of basic medical sciences 16 (4), 298, 2016 | 37 | 2016 |
| Importance of inflammatory markers and IL-6 for diagnosis and follow up of patients with type 2 diabetes mellitus. M Malenica, M Šilar, T Dujić, T Bego, S Semiz, S Škrbo, B Prnjavorac, ... Medicinski Glasnik 14 (2), 2017 | 34 | 2017 |
| Perceptions of students in health and molecular life sciences regarding pharmacogenomics and personalized medicine L Mahmutovic, B Akcesme, C Durakovic, FB Akcesme, A Maric, M Adilovic, ... Human Genomics 12, 1-15, 2018 | 33 | 2018 |
| Analysis of CYP2C9* 2, CYP2C19* 2, and CYP2D6* 4 polymorphisms in patients with type 2 diabetes mellitus S Semiz, T Dujic, B Ostanek, B Prnjavorac, T Bego, M Malenica, J Marc, ... Bosnian journal of basic medical sciences 10 (4), 287, 2010 | 33 | 2010 |